Ergoteles LLC Staar Surgical CO Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$51.25 - $79.34 $377,507 - $584,418	7,366 Added 116.22%	13,704 $876,000
Q4 2022 Feb 14, 2023	BUY	$46.82 - $76.2 $155,208 - $252,603	3,315 Added 109.66%	6,338 $307,000
Q3 2022 Nov 14, 2022	SELL	$70.55 - $111.58 $294,828 - $466,292	-4,179 Reduced 58.03%	3,023 $213,000
Q2 2022 Aug 12, 2022	BUY	$50.24 - $80.48 $361,828 - $579,616	7,202 New	7,202 $511,000
Q1 2022 May 13, 2022	SELL	$57.98 - $93.5 $1.04 Million - $1.67 Million	-17,859 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$88.02 - $127.79 $808,111 - $1.17 Million	9,181 Added 105.8%	17,859 $1.63 Million
Q3 2021 Nov 15, 2021	BUY	$122.75 - $162.68 $1.07 Million - $1.41 Million	8,678 New	8,678 $1.12 Million

251

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.11B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.